Lisa Rojkjaer Insider Profile
11 Followers
Lisa Rojkjaer, EVP, Chief Medical Officer at Rigel, holds 34.00K shares in Rigel (Ticker: RIGL), holds 48.09K shares in Viracta Therapeutics (Ticker: VIRX).
Lisa Rojkjaer has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
EVP, Chief Medical Officer
Roles that Lisa Rojkjaer holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Lisa Rojkjaer
Lisa Rojkjaer's Trading History
Rigel
Jun 03, 2026
EVP, Chief Medical Officer
Uninformative Sell
25.38K
$1.61M
Viracta Therapeutics
Feb 28, 2023
―
Uninformative Buy
3.43K
$480.87
List of latest transactions for each holding click on a transaction to see Lisa Rojkjaer's performance on stock
You May Also Like
Lisa Rojkjaer insider profile FAQ
What is the percentage of profitable transactions made by Lisa Rojkjaer?
The percentage of profitable transactions made by Lisa Rojkjaer is ―.
What is the average return per transaction made by Lisa Rojkjaer?
The average return per transaction made by Lisa Rojkjaer is ―.
What stocks does Lisa Rojkjaer hold?
Lisa Rojkjaer holds: RIGL, VIRX stocks.
What was Lisa Rojkjaer’s latest transaction?
Lisa Rojkjaer latest transaction was an Uninformative Sell of $25.38K.
What was Lisa Rojkjaer's most profitable transaction?
Lisa Rojkjaer’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Lisa Rojkjaer's role in Rigel?
Lisa Rojkjaer's role in Rigel is EVP, Chief Medical Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.